IIRC, the actual article says they're going to do a large trial, with 150k people, and someone in the article expresses skepticism that the estimated FP rate of 0.5% is accurate, because so far it was tested in people where there's some evidence of cancer.
I.e., higher FP rate, and it wouldn't be rolled out.